Search
Monopar Therapeutics Inc
MNPRAdd to Watchlist
67.470USD
+3.080+4.78%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
451.99MMarket Cap
LossP/E TTM
Monopar Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Monopar Therapeutics Inc is 9.29, ranking 42 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -34.94, which is -94.18% below the recent high of -2.03 and -71.97% above the recent low of -60.08.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
